Yihong Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yihong Cheng has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Bin Zhang
Department of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications - Leqin Fang
Department of Psychiatry, Sleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications - Aike Wu
Department of Psychiatry, Sleep Medicine Center, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, China
1 shared publication - Dan Zhou
Department of Psychiatry, Sleep Medicine Center, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, China
1 shared publication - Dhirendra Paudel
Department of Psychiatry Sleep Medicine Center Nanfang Hospital Southern Medical University Guangzhou Guangdong China
1 shared publication - Hangyi Yang
Department of Psychiatry, Sleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by IMR Press in ALPHA PSYCHIATRY
- Vol. 26 (6)
Circadian Variations in Cognitive Performance Among Patients With Narcolepsy and Obstructive Sleep Apnea: A Comparative Study
Background: Patients with narcolepsy experience excessive daytime sleepiness (EDS) and cognitive impairment. However, studies on the circadian variability associated with cognitive impairment in narcolepsy patients are scarce. This study aimed to explore circadian cognitive performance in narcolepsy patients compared with patients with obstructive sleep apnea (OSA) and EDS (OSA-with-EDS). Methods: A total of 62 participants, 29 with narcolepsy and 33 with OSA-with-EDS completed the study. The assessments were done using questionnaires, polysomnography (PSG), the multiple sleep latency test (MSLT), and cognitive-behavioral tasks at different time points (20:00, 08:00, 10:00, 12:00, 14:00, 16:00, and 18:00) including the psychomotor vigilance task (PVT), the Stroop color-word task, and the 2-back task to separately assess the circadian variations of vigilant attention, inhibitory control, and working memory respectively. Results: Narcolepsy patients showed significant within-subject circadian variations in vigilant attention (p < 0.001), inhibitory control (p = 0.016), and working memory (p < 0.001) in the time domain. Overall, vigilant attention in narcolepsy patients presented a pattern with optimal performance observed at 20:00 on the previous night followed by deterioration in the morning (08:00~14:00) and improvement in the afternoon (14:00~18:00). Inhibitory control displayed a pattern of “enhancement in the morning (08:00~12:00) followed by a decline in the afternoon (12:00~18:00)”, while working memory displayed a trend of improvement during daytime hours, with these two measures showing their poorest performance at 20:00 on the previous night. Conclusions: Circadian variations were prominently observed in vigilant attention, inhibitory control, and working memory performance among patients with narcolepsy. Except for EDS, the intrinsic disease specificity may play an important role in the cognitive impairments associated with narcolepsy.
- 1 December 2025
- Published by IMR Press in ALPHA PSYCHIATRY
- Vol. 26 (6)
Open AccessCircadian Variations in Cognitive Performance Among Patients With Narcolepsy and Obstructive Sleep Apnea: A Comparative Study
Background: Patients with narcolepsy experience excessive daytime sleepiness (EDS) and cognitive impairment. However, studies on the circadian variability associated with cognitive impairment in narcolepsy patients are scarce. This study aimed to explore circadian cognitive performance in narcolepsy patients compared with patients with obstructive sleep apnea (OSA) and EDS (OSA-with-EDS). Methods: A total of 62 participants, 29 with narcolepsy and 33 with OSA-with-EDS completed the study. The assessments were done using questionnaires, polysomnography (PSG), the multiple sleep latency test (MSLT), and cognitive-behavioral tasks at different time points (20:00, 08:00, 10:00, 12:00, 14:00, 16:00, and 18:00) including the psychomotor vigilance task (PVT), the Stroop color-word task, and the 2-back task to separately assess the circadian variations of vigilant attention, inhibitory control, and working memory respectively. Results: Narcolepsy patients showed significant within-subject circadian variations in vigilant attention (p < 0.001), inhibitory control (p = 0.016), and working memory (p < 0.001) in the time domain. Overall, vigilant attention in narcolepsy patients presented a pattern with optimal performance observed at 20:00 on the previous night followed by deterioration in the morning (08:00~14:00) and improvement in the afternoon (14:00~18:00). Inhibitory control displayed a pattern of “enhancement in the morning (08:00~12:00) followed by a decline in the afternoon (12:00~18:00)”, while working memory displayed a trend of improvement during daytime hours, with these two measures showing their poorest performance at 20:00 on the previous night. Conclusions: Circadian variations were prominently observed in vigilant attention, inhibitory control, and working memory performance among patients with narcolepsy. Except for EDS, the intrinsic disease specificity may play an important role in the cognitive impairments associated with narcolepsy.
- Open Access
- 1 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1) , 8836588
Differential Anxiety–Depression–CRP Network Structures Across Insomnia Severity Levels: Evidence From UK Biobank
Background: This study investigated the relationships between anxiety, depression symptoms, and C‐reactive protein (CRP) across insomnia severity levels using network analysis and examined the structural differences within these networks. Methods: Gaussian graphical model network analysis with Least Absolute Shrinkage and Selection Operator (LASSO) regularization was conducted on UK Biobank data ( N = 143,027). Depression and anxiety symptoms were assessed using the 9‐item Patient Health Questionnaire (PHQ‐9) and 7‐item Generalized Anxiety Disorder Scale (GAD‐7), respectively. CRP was quantified using immunoturbidimetric‐high‐sensitivity analysis. Participants were categorized by insomnia frequency (never/rarely, sometimes, and usually). The strength symptoms and expected influence identified core symptoms, while bridge expected influence (bridge EI) determined bridge symptoms. Network comparison tests (NCTs) were performed pairwise across the three groups to assess differences in global strength and edge weights. Results: Across all networks, “Depressed mood” demonstrated the highest strength centrality, while “Irritability” exhibited the highest bridge EI. “Depressed mood” had the highest expected influence centrality in the never/rarely insomnia group and “Uncontrollable worry” in other groups. NCTs revealed significant differences in global strength ( S = 0.178, p < 0.01) and edge weights ( M = 0.062, p < 0.01) between the never/rarely and usually insomnia groups, with stronger connections between depressive symptoms (energy/appetite) and CRP in the usually insomnia group ( p < 0.001). Conclusions: The central roles of depressed mood, uncontrollable worry, and irritability in the anxiety–depression–CRP network across all insomnia severity groups suggest that these symptoms represent potential targets for future intervention research. Notably, network structure differed across insomnia severity; the strengthened associations between depressive symptoms and CRP in the usually insomnia group suggest that insomnia severity may be an important factor to consider in understanding the relationships between affective and inflammatory processes.
- 1 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1) , 8836588
Open AccessDifferential Anxiety–Depression–CRP Network Structures Across Insomnia Severity Levels: Evidence From UK Biobank
Background: This study investigated the relationships between anxiety, depression symptoms, and C‐reactive protein (CRP) across insomnia severity levels using network analysis and examined the structural differences within these networks. Methods: Gaussian graphical model network analysis with Least Absolute Shrinkage and Selection Operator (LASSO) regularization was conducted on UK Biobank data ( N = 143,027). Depression and anxiety symptoms were assessed using the 9‐item Patient Health Questionnaire (PHQ‐9) and 7‐item Generalized Anxiety Disorder Scale (GAD‐7), respectively. CRP was quantified using immunoturbidimetric‐high‐sensitivity analysis. Participants were categorized by insomnia frequency (never/rarely, sometimes, and usually). The strength symptoms and expected influence identified core symptoms, while bridge expected influence (bridge EI) determined bridge symptoms. Network comparison tests (NCTs) were performed pairwise across the three groups to assess differences in global strength and edge weights. Results: Across all networks, “Depressed mood” demonstrated the highest strength centrality, while “Irritability” exhibited the highest bridge EI. “Depressed mood” had the highest expected influence centrality in the never/rarely insomnia group and “Uncontrollable worry” in other groups. NCTs revealed significant differences in global strength ( S = 0.178, p < 0.01) and edge weights ( M = 0.062, p < 0.01) between the never/rarely and usually insomnia groups, with stronger connections between depressive symptoms (energy/appetite) and CRP in the usually insomnia group ( p < 0.001). Conclusions: The central roles of depressed mood, uncontrollable worry, and irritability in the anxiety–depression–CRP network across all insomnia severity groups suggest that these symptoms represent potential targets for future intervention research. Notably, network structure differed across insomnia severity; the strengthened associations between depressive symptoms and CRP in the usually insomnia group suggest that insomnia severity may be an important factor to consider in understanding the relationships between affective and inflammatory processes.